Dr. Jamak Modaresi Esfeh, MD

Dr. Modaresi Esfeh practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Modaresi Esfeh's NPI, 1326363326, was assigned on April 1, 2010. Dr. Modaresi Esfeh holds Ohio license 35.128973.

Dr. Modaresi Esfeh's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Modaresi Esfeh's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Modaresi Esfeh is also affiliated with Medina Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Modaresi Esfeh to 3 more hospitals and 2 clinical labs, each named with a free account. Dr. Modaresi Esfeh's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Modaresi Esfeh practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Modaresi Esfeh's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Modaresi Esfeh is licensed in Ohio.

CMS data shows 353 Medicare services from Dr. Modaresi Esfeh across 9 procedure codes in 2024, for 214 Medicare patients. Medicare paid $22,315 for them.

CMS counts 214 Medicare patients who saw Dr. Modaresi Esfeh in 2024. The largest group is 65 to 74, with 125 patients. 72% of them have high blood pressure, and 71% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Modaresi Esfeh's median patient age at 59, with 54% women.

In 2024, Dr. Modaresi Esfeh wrote 604 Medicare Part D claims for 120 patients. 87% of them were for generic drugs. CMS names the drug for 540 of them, across 16 drugs with 11 or more claims each, at $259,977 in total drug cost. In 2023, CMS named 437 claims across 16 drugs.

Dr. Modaresi Esfeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Modaresi Esfeh as offering telehealth. CMS counts 21 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Modaresi Esfeh, more than 51% of the clinicians it reports for that procedure.

Dmand AI links 35 papers to Dr. Modaresi Esfeh, published from 2014 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Liver Transplantation, Liver Cirrhosis and End Stage Liver Disease. Dr. Modaresi Esfeh has published most often in Gastroenterol Rep (Oxf). Dr. Modaresi Esfeh's most frequent co-authors are Federico N. Aucejo, MD, Andrea Schlegel, MBA, MD and Chase Jett Wehrle, MD.

CMS Open Payments shows 4 general payments to Dr. Modaresi Esfeh from 2 drug and device companies from 2016 to 2023. Speaker and faculty fees make up the largest share, 99% of the total. Bausch Health Americas, Inc. paid the most, $2,250.